| Name | 1-{4-[2-(4-Bromophenyl)-1,3-dioxolan-2-yl]-1-piperidinyl}-2,2,2-t rifluoroethanone |
|---|---|
| Synonyms |
4-[2-morpholinoethoxy]phenyl bromide
1-bromo-4-(2-morpholinoethoxy)benzene 4-[2-(4-bromo-phenoxy)-ethyl]-morpholine N-(4-bromophenoxyethyl)morpholine 4-[2-(4-bromophenyl)-1,3-dioxolan-2-yl]-1-trifluoroacetyl-piperidine |
| Molecular Formula | C16H17BrF3NO3 |
|---|---|
| Molecular Weight | 408.21000 |
| Exact Mass | 407.03400 |
| PSA | 38.77000 |
| LogP | 3.38750 |
|
~%
203187-77-3 |
| Literature: SCHERING CORPORATION Patent: EP1175402 B1, 2005 ; Location in patent: Page/Page column 30 ; |
|
~%
203187-77-3 |
| Literature: Palani; Shapiro; Clader; Greenlee; Cox; Strizki; Endres; Baroudy Journal of Medicinal Chemistry, 2001 , vol. 44, # 21 p. 3339 - 3342 |
|
~%
203187-77-3 |
| Literature: Palani; Shapiro; Clader; Greenlee; Cox; Strizki; Endres; Baroudy Journal of Medicinal Chemistry, 2001 , vol. 44, # 21 p. 3339 - 3342 |
|
~%
203187-77-3 |
| Literature: Palani; Shapiro; Clader; Greenlee; Cox; Strizki; Endres; Baroudy Journal of Medicinal Chemistry, 2001 , vol. 44, # 21 p. 3339 - 3342 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |